| Dr Jessica Jones Croley, MD | |
|
3470 Blazer Pkwy, Suite 150, Lexington, KY 40509-1200 | |
| (859) 629-7110 | |
| (859) 543-1989 |
| Full Name | Dr Jessica Jones Croley |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 17 Years |
| Location | 3470 Blazer Pkwy, Lexington, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629231170 | NPI | - | NPPES |
| 7100237370 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 43781 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Joseph East | Lexington, KY | Hospital |
| Saint Joseph Hospital | Lexington, KY | Hospital |
| Baptist Health Lexington | Lexington, KY | Hospital |
| Saint Joseph Mount Sterling | Mount sterling, KY | Hospital |
| Saint Joseph Berea | Berea, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Saint Joseph Health System Inc | 4183641400 | 34 |
News Archive
A new iPhone application, created by researchers at Children's Hospital Boston in collaboration with the MIT Media Lab, enables users to track and report outbreaks of infectious diseases, such as H1N1 (swine flu), on the ground in real time.
Ranbaxy Laboratories Limited said today that recently, in two separate rulings, the Spanish courts (the Mercantile Court of Barcelona, No. 2) found Spanish patent ES 2,167,306 (counterpart of Pfizer's EP 409 281) to be invalid for lack of novelty.
Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.
USGI Medical, Inc. announced that a prominent surgeon in Italy performed the first POSE procedure on patients for weight loss.
A study of pharmaceutical companies' marketing to physicians shows that doctors are most influenced by brand preference and marketing that addresses the problems of drugs with many side effects, according to the Management Insights feature in the current issue of Management Science, the flagship journal of the Institute for Operations Research and the Management Sciences (INFORMS).
› Verified 7 days ago
| Entity Name | Saint Joseph Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659624435 PECOS PAC ID: 4183641400 Enrollment ID: O20051026000806 |
News Archive
A new iPhone application, created by researchers at Children's Hospital Boston in collaboration with the MIT Media Lab, enables users to track and report outbreaks of infectious diseases, such as H1N1 (swine flu), on the ground in real time.
Ranbaxy Laboratories Limited said today that recently, in two separate rulings, the Spanish courts (the Mercantile Court of Barcelona, No. 2) found Spanish patent ES 2,167,306 (counterpart of Pfizer's EP 409 281) to be invalid for lack of novelty.
Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.
USGI Medical, Inc. announced that a prominent surgeon in Italy performed the first POSE procedure on patients for weight loss.
A study of pharmaceutical companies' marketing to physicians shows that doctors are most influenced by brand preference and marketing that addresses the problems of drugs with many side effects, according to the Management Insights feature in the current issue of Management Science, the flagship journal of the Institute for Operations Research and the Management Sciences (INFORMS).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jessica Jones Croley, MD Po Box 936, London, KY 40743-0936 Ph: (606) 330-7818 | Dr Jessica Jones Croley, MD 3470 Blazer Pkwy, Suite 150, Lexington, KY 40509-1200 Ph: (859) 629-7110 |
News Archive
A new iPhone application, created by researchers at Children's Hospital Boston in collaboration with the MIT Media Lab, enables users to track and report outbreaks of infectious diseases, such as H1N1 (swine flu), on the ground in real time.
Ranbaxy Laboratories Limited said today that recently, in two separate rulings, the Spanish courts (the Mercantile Court of Barcelona, No. 2) found Spanish patent ES 2,167,306 (counterpart of Pfizer's EP 409 281) to be invalid for lack of novelty.
Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.
USGI Medical, Inc. announced that a prominent surgeon in Italy performed the first POSE procedure on patients for weight loss.
A study of pharmaceutical companies' marketing to physicians shows that doctors are most influenced by brand preference and marketing that addresses the problems of drugs with many side effects, according to the Management Insights feature in the current issue of Management Science, the flagship journal of the Institute for Operations Research and the Management Sciences (INFORMS).
› Verified 7 days ago
Mr. Fabrizio Canepa Escaro, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: Uk Division Of Hospital Medicine 800 Rose, Lexington, KY 40536 Phone: 859-323-6047 Fax: 859-257-3873 | |
Dr. Moneera Nur Haque, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 125 E Maxwell St Ste 200, Lexington, KY 40508 Phone: 859-323-3231 Fax: 859-257-9461 | |
Dr. Indhira Bisono Jimenez, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 211 Fountain Ct, Suite 220, Lexington, KY 40509 Phone: 859-629-7265 Fax: 859-629-7266 | |
Deepali Pandey, MBBS Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 800 Rose St # Cc-402, Lexington, KY 40536 Phone: 650-804-3111 | |
Dr. Dorothy Mccord Maes, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1000 S Limestone, Lexington, KY 40536 Phone: 859-323-9057 Fax: 859-323-9502 | |
Dr. Stephen M Mooney, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2101 Nicholasville Rd Ste 304, Lexington, KY 40503 Phone: 859-277-5771 Fax: 859-276-4622 | |
Michael Han Young, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 740 S Limestone, Lexington, KY 40536 Phone: 859-323-5544 Fax: 859-257-9286 |